These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 4122479)

  • 21. [Treatment of pulmonary tuberculosis in developing countries].
    Larbaoui D
    Tunis Med; 1974; 52(2):59-66. PubMed ID: 4140601
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug resistant pulmonary tuberculosis treated with ethambutol and rifampicin in North East England.
    Somner AR; Selkon JB; Walton M; White AB
    Tubercle; 1973 Jun; 54(2):141-5. PubMed ID: 4203159
    [No Abstract]   [Full Text] [Related]  

  • 23. [Modern tuberculosis therapy].
    Krohn J
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2576-8. PubMed ID: 4772808
    [No Abstract]   [Full Text] [Related]  

  • 24. Rifampin in the treatment of pulmonary tuberculosis.
    Hyde L
    Calif Med; 1972 Dec; 117(6):18-21. PubMed ID: 4635395
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 26. Recent trends in tuberculosis care.
    Clark MA
    Nurs Clin North Am; 1974 Mar; 9(1):157-64. PubMed ID: 4375279
    [No Abstract]   [Full Text] [Related]  

  • 27. Rifampin plus isoniazid in initial therapy of pulmonary tuberculosis and rifampin and ethambutol in retreatment cases.
    Lees AW; Allan GW; Smith J; Tyrell WF; Fallon RJ
    Chest; 1972 Jun; 61(6):579-82. PubMed ID: 4260668
    [No Abstract]   [Full Text] [Related]  

  • 28. [Proceedings: Rifampicin adverse effects in intermittent therapy].
    Herrmann H; Eule H; Lau W; Kuhnert R; Fanter D; Kahlau U; Schönert E; Werner E
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):146-58. PubMed ID: 4491712
    [No Abstract]   [Full Text] [Related]  

  • 29. Rifampicin: a first line tuberculostatic drug. A critical review and appraisal.
    Saerens EJ
    Acta Tuberc Pneumol Belg; 1972; 63(6):516-28. PubMed ID: 4206441
    [No Abstract]   [Full Text] [Related]  

  • 30. [Five year follow-up study on the short-course chemotherapy for pulmonary tuberculosis in Niigata Prefecture].
    Hashimoto T; Shimao T; Aoki M; Misawa H; Takasawa N; Shiozawa S
    Kekkaku; 1984 Jun; 59(6):369-76. PubMed ID: 6492547
    [No Abstract]   [Full Text] [Related]  

  • 31. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 32. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F; Perusi O
    G Ital Mal Torace; 1966; 20(6):365-78. PubMed ID: 5997781
    [No Abstract]   [Full Text] [Related]  

  • 33. [Humoral and bacteriological findings in patients with pulmonary tuberculosis during rifampicin therapy].
    Stringa C
    G Ital Mal Torace; 1969; ():Suppl 2:107-8. PubMed ID: 5357133
    [No Abstract]   [Full Text] [Related]  

  • 34. Recent developments in the treatment of infectious diseases. V. Management of tuberculosis in the community hospital.
    Marr JJ
    Mo Med; 1971 Nov; 68(11):857-63. PubMed ID: 5096634
    [No Abstract]   [Full Text] [Related]  

  • 35. [Early results of sputum-positive patients with newly-detected pulmonary tuberculosis with rifampicin combined with isoniazid and SM (preliminary report)].
    Ropek M; Szymański A; Banaszkiewicz H; Chetkowski A; Czaplińska-Jóźwiak E; Dabrowska-Solecka Z; Ignaczak J; Kondratowicz W; Królikowska H; Pawlik J; Pawlowska I; Sliwińska M; Szuster I; Szymánska W
    Gruzlica; 1973 Jul; 41(7):777-80. PubMed ID: 4730978
    [No Abstract]   [Full Text] [Related]  

  • 36. [New drugs in antitubercular therapy].
    Favez G
    Helv Med Acta Suppl; 1969; 49():66-80. PubMed ID: 4912509
    [No Abstract]   [Full Text] [Related]  

  • 37. [Treatment of tuberculosis].
    Vale JR
    Tidsskr Nor Laegeforen; 1975 Dec; 95(34-36):1991-2. PubMed ID: 1209576
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of pulmonary tuberculosis by combined rifampicin-isoniazid-streptomycin, and return to work after the 45th day].
    Kreis B; Israël L; Pretet S
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1091-108. PubMed ID: 5387445
    [No Abstract]   [Full Text] [Related]  

  • 39. [Proceedings: Significance and limits of controlled clinical research (in pulmonary tuberculosis)].
    Bignall JR
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):103-6. PubMed ID: 4588016
    [No Abstract]   [Full Text] [Related]  

  • 40. Aspects of the tuberculosis situation in Denmark, especially chemoresistance.
    Kok-Jensen A; Torning K
    Scand J Respir Dis Suppl; 1969; 69():17-20. PubMed ID: 4906371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.